1-6 of 6
Alicia Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Investigating the Potential Impact of Dosing Tolerance to Facilitate Use of Nplate Self-Administration in Adult Patients with ITP

Florencio Serrano Castillo, Hossam A Saad, Kejia Wang, Alicia Zhang, Vincent Chow, Sameer Doshi
Journal: Blood
Blood (2021) 138 (Supplement 1): 4231.
https://doi.org/10.1182/blood-2021-153195
Published: 2021
Journal Articles

Open-Label, Phase 2 Study of Blinatumomab As Second Salvage Therapy in Adults with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

Luke Coyle, Nicholas J. Morley, Alessandro Rambaldi, MD, Kylie D. Mason, MBBS, MD FRACP, FRCPA, PhD, Gregor Verhoef, MDPhD, Caroline Furness, Alicia Zhang, A. Scott Jung, Janet L. Franklin
Journal: Blood
Blood (2018) 132 (Supplement 1): 400.
https://doi.org/10.1182/blood-2018-99-112280
Published: 2018
Journal Articles

Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Andreas Viardot, Marie-Elisabeth Goebeler, Georg Hess, Svenja Neumann, Michael Pfreundschuh, Nicole Adrian, Florian Zettl, Martin Libicher, Cyrus Sayehli, Julia Stieglmaier, Alicia Zhang, Dirk Nagorsen, Ralf C. Bargou
Journal: Blood
Blood (2016) 127 (11): 1410–1416.
https://doi.org/10.1182/blood-2015-06-651380
Published: 2016
Includes: Supplemental data
Journal Articles

Treatment with Anti-CD19 BiTE ® Blinatumomab in Adult Patients with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (r/r ALL) Post-Allogeneic Hematopoietic Stem Cell Transplantation

Anthony Selwyn Stein, MD, Max S. Topp, MD, Hagop M Kantarjian, MD, Nicola Goekbuget, MD, Ralf C Bargou, MD, Mark R Litzow, MD, Alessandro Rambaldi, MD, Josep Ribera, MD PhD, Alicia Zhang, PhD, Zachary Zimmerman, MD PhD, Stephen J. Forman, MD
Journal: Blood
Blood (2015) 126 (23): 861.
https://doi.org/10.1182/blood.V126.23.861.861
Published: 2015
Journal Articles

Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma with the Bispecific T-Cell Engager (BiTE ® ) Antibody Construct Blinatumomab: Primary Analysis Results from an Open-Label, Phase 2 Study

Andreas Viardot, Mariele Goebeler, Georg Hess, Svenja Neumann, Michael Pfreundschuh, Nicole Adrian, Florian Zettl, Martin Libicher, Evelyn Degenhard, Julia Stieglmaier, Alicia Zhang, Dirk Nagorsen, Ralf C. Bargou
Journal: Blood
Blood (2014) 124 (21): 4460.
https://doi.org/10.1182/blood.V124.21.4460.4460
Published: 2014
Journal Articles

Open-Label Phase 2 Study Of The Bispecific T-Cell Engager (BiTE ® ) Blinatumomab In Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Andreas Viardot, Mariele Goebeler, Michael Pfreundschuh, Nicole Adrian, Martin Libicher, Evelyn Degenhard, Julia Stieglmaier, Alicia Zhang, Dirk Nagorsen, Ralf C. Bargou
Journal: Blood
Blood (2013) 122 (21): 1811.
https://doi.org/10.1182/blood.V122.21.1811.1811
Published: 2013